AstraZeneca is withdrawing its Covid-19 vaccine less than four years after its UK launch after a “surplus” of drugs targeting newer variants led to sinking demand for the jab.
阿斯利康(AstraZeneca)在英国推出新冠疫苗不到四年后下架了该疫苗，原因是针对新变种的疫苗“过剩”，导致对该疫苗的需求下降。
您已阅读6%（241字），剩余94%（3485字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。